Not a member yet? Register here
Nivolumab plus gemcitabine-cisplatin combination therapy in advanced urothelial carcinoma
Atezolizumab plus bevacizumab vs. surveillance in patients with hepatocellular carcinoma
Selpercatinib outperforms cabozantinib and vandetanib in
-mutant medullary thyroid cancer
Amivantamab improves efficacy outcomes in NSCLC patients with EGFR exon 20 insertions
Impact of contrast-enhanced MRI in shaping treatment plans for patients with colorectal liver ...
Adding abemaciclib to first line endocrine therapy prolongs the median OS with more than a yea...
Index latest issue
Photobiomodulation and gynaecological cancer therapy-related complications: What is known?
Update metastatic cutaneous melanoma: Increasing the therapeutic armamentarium
Revision of the guidelines ‘Care in the dying phase’
A rare tumour of the lacrimal gland: Immunoglobulin G4-related pseudo tumour
Optimising treatment and follow-up of patients with bladder cancer: Risk stratification and biomarkers
All.Can Belgium Lung Cancer Working Group: Ready for take-off
New oncology reimbursements in Belgium
Want to know more about cancer prevention?
PANDA emerges as a promising tool for large-scale pancreatic cancer screening
Belzutifan significantly outperforms everolimus in previously treated patients with advanced c...
Regional node radiotherapy for early breast cancer significantly reduced mortality in post-198...